Cleveland Clinic icon
Consult QD logo

Tumor Oncology

microRCC_650x450
February 16, 2019/Cancer/Tumor Oncology

KEYNOTE-426: Pembrolizumab + Axitinib or Sunitinib Alone for Advanced Renal Cell Carcinoma?

Combo therapy shows longer OS and PFS and higher ORR

pancreatic-cancer-cell-650×450
February 15, 2019/Cancer/Tumor Oncology

Short-Term S1505 Results Point to Prospective Radiological Review

Preoperative chemo approach in pancreatic cancer

nci-vol-10546-72_650x450
January 4, 2019/Cancer/Tumor Oncology

SELECT Trial Finds TKIs Delay Recurrence but May Not Improve Cure Rate

More time on drug may be needed

Valente-breast-surg_650x450
December 7, 2018/Cancer/Tumor Oncology

Breast Reconstruction Complications Not Linked to Breast Cancer Recurrence

Tumor factors are more significant, says new study

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

DrKalady_690x380
August 4, 2015/Cancer/Tumor Oncology

Researchers Find Possible Cause of Treatment Resistance in Colorectal Cancer

Cytokine IL-17A may drive cancer stem cell growth

Clear-cell-RCC_690x380.2
July 15, 2015/Cancer/Tumor Oncology

Improving Prediction of Recurrence Risk in Clear Cell Renal Cell Carcinoma

Researchers validate a 16-gene assay

abraham_690x380
April 16, 2015/Cancer/Tumor Oncology

Breast Cancer Program Launches Tumor Board Webcast Video Series

Viewers ‘sit in’ on complex patient care reviews

rini_690-x-380
May 27, 2014/Cancer/Tumor Oncology

Report Details Renal Cell Cancer Treatment Gaps

Evidence-based medicine can raise the standard of care

liver-690×380
April 15, 2014/Cancer/Tumor Oncology

Liver Radioembolization Doubles Survival Time

Palliative Y90 treatment may get earlier application

BackPage 3 of 3Next

Advertisement

Ad